Esteve invests €71M to expand China plant, boosting Asia presence

Spanish pharma group Esteve is investing €71 million to expand and modernize its China plant, increasing third-party manufacturing capacity. This signals continued foreign investment in China's pharma sector despite geopolitical tensions. The move strengthens Esteve's Asian footprint and may reflect growing demand for contract manufacturing in the region.